|
1.
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar
|
|
2.
|
Roukos DH: Current status and future
perspectives in gastric cancer management. Cancer Treat Rev.
26:243–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Fiedorek SC, Malaty HM, Evans DL, Pumphrey
CL, Casteel HB, Evans DJ Jr and Graham DY: Factors influencing the
epidemiology of Helicobacter pylori infection in children.
Pediatrics. 88:578–582. 1991.PubMed/NCBI
|
|
4.
|
Plummer M, Franceschi S and Munoz N:
Epidemiology of gastric cancer. IARC Sci Publ. 2004:311–326.
2004.
|
|
5.
|
Lunet N, Valbuena C, Vieira AL, Lopes C,
Lopes C, David L, Carneiro F and Barros H: Fruit and vegetable
consumption and gastric cancer by location and histological type:
case-control and meta-analysis. Eur J Cancer Prev. 16:312–327.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kaaks R, Tuyns AJ, Haelterman M and Riboli
E: Nutrient intake patterns and gastric cancer risk: a case-control
study in Belgium. Int J Cancer. 78:415–420. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Palli D, Russo A and Decarli A: Dietary
patterns, nutrient intake and gastric cancer in a high-risk area of
Italy. Cancer Causes Control. 12:163–172. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
De Stefani E, Correa P, Boffetta P,
Deneo-Pellegrini H, Ronco AL and Mendilaharsu M: Dietary patterns
and risk of gastric cancer: a case-control study in Uruguay.
Gastric Cancer. 7:211–220. 2004.
|
|
9.
|
Asano K, Kubo M, Yonemoto K, Doi Y,
Ninomiya T, Tanizaki Y, Arima H, Shirota T, Matsumoto T, Iida M and
Kiyohara Y: Impact of serum total cholesterol on the incidence of
gastric cancer in a population-based prospective study: the
Hisayama study. Int J Cancer. 122:909–914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Dessi S, Batetta B, Pulisci D, Spano O,
Anchisi C, Tessitore L, Costelli P, Baccino FM, Aroasio E and Pani
P: Cholesterol content in tumor tissues is inversely associated
with high-density lipoprotein cholesterol in serum in patients with
gastrointestinal cancer. Cancer. 73:253–258. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jafri H, Alsheikh-Ali AA and Karas RH:
Baseline and on-treatment high-density lipoprotein cholesterol and
the risk of cancer in randomized controlled trials of
lipid-altering therapy. J Am Coll Cardiol. 55:2846–2854
|
|
12.
|
Levy RI: Cholesterol and disease - what
are the facts? JAMA. 248:2888–2890. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Eichholzer M, Stahelin HB, Gutzwiller F,
Ludin E and Bernasconi F: Association of low plasma cholesterol
with mortality for cancer at various sites in men: 17-y follow-up
of the prospective Basel study. Am J Clin Nutr. 71:569–574.
2000.PubMed/NCBI
|
|
14.
|
Kritchevsky SB and Kritchevsky D: Serum
cholesterol and cancer risk: an epidemiologic perspective. Annu Rev
Nutr. 12:391–416. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Schatzkin A, Hoover RN, Taylor PR, Ziegler
RG, Carter CL, Larson DB and Licitra LM: Serum cholesterol and
cancer in the NHANES I epidemiologic follow-up study. National
Health and Nutrition Examination Survey. Lancet. 2:298–301. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tornberg SA, Holm LE, Carstensen JM and
Eklund GA: Cancer incidence and cancer mortality in relation to
serum cholesterol. J Natl Cancer Inst. 81:1917–1921. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wannamethee G, Shaper AG, Whincup PH and
Walker M: Low serum total cholesterol concentrations and mortality
in middle aged British men. BMJ. 311:409–413. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Brunet A, Pages G and Pouyssegur J:
Constitutively active mutants of MAP kinase kinase (MEK1) induce
growth factor-relaxation and oncogenicity when expressed in
fibroblasts. Oncogene. 9:3379–3387. 1994.PubMed/NCBI
|
|
19.
|
Edidin M: The state of lipid rafts: from
model membranes to cells. Annu Rev Biophys Biomol Struct.
32:257–283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Zhuang L, Kim J, Adam RM, Solomon KR and
Freeman MR: Cholesterol targeting alters lipid raft composition and
cell survival in prostate cancer cells and xenografts. J Clin
Invest. 115:959–968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhuang L, Lin J, Lu ML, Solomon KR and
Freeman MR: Cholesterol-rich lipid rafts mediate akt-regulated
survival in prostate cancer cells. Cancer Res. 62:2227–2231.
2002.PubMed/NCBI
|
|
22.
|
Gajate C, Gonzalez-Camacho F and Mollinedo
F: Involvement of raft aggregates enriched in Fas/CD95
death-inducing signaling complex in the antileukemic action of
edelfosine in Jurkat cells. PLoS One. 4:e50442009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Mollinedo F and Gajate C: Fas/CD95 death
receptor and lipid rafts: new targets for apoptosis-directed cancer
therapy. Drug Resist Updat. 9:51–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Iribarren C, Reed DM, Chen R, Yano K and
Dwyer JH: Low serum cholesterol and mortality. Which is the cause
and which is the effect? Circulation. 92:2396–2403. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kitahara CM, Berrington de Gonzalez A,
Freedman ND, Huxley R, Mok Y, Jee SH and Samet JM: Total
cholesterol and cancer risk in a large prospective study in Korea.
J Clin Oncol. 29:1592–1598
|
|
26.
|
Schuit AJ, Van Dijk CE, Dekker JM,
Schouten EG and Kok FJ: Inverse association between serum total
cholesterol and cancer mortality in Dutch civil servants. Am J
Epidemiol. 137:966–976. 1993.PubMed/NCBI
|
|
27.
|
Tornberg SA, Carstensen JM and Holm LE:
Risk of stomach cancer in association with serum cholesterol and
beta-lipoprotein. Acta Oncol. 27:39–42. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Tabas I: Consequences of cellular
cholesterol accumulation: basic concepts and physiological
implications. J Clin Invest. 110:905–911. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Yao PM and Tabas I: Free cholesterol
loading of macrophages induces apoptosis involving the fas pathway.
J Biol Chem. 275:23807–23813. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Yao PM and Tabas I: Free cholesterol
loading of macrophages is associated with widespread mitochondrial
dysfunction and activation of the mitochondrial apoptosis pathway.
J Biol Chem. 276:42468–42476. 2001. View Article : Google Scholar : PubMed/NCBI
|
